MyAverix Finance
NS · Pharmaceuticals
Wockhardt Ltd (WOCKPHARMA)
Pharmaceuticals & Biotechnology
Wockhardt Ltd (WOCKPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $325.63B, P/E ratio is 102.72, net margin is -6.4%, dividend yield is 0.50%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for WOCKPHARMA
Wockhardt Ltd (WOCKPHARMA) — FAQ
What is Wockhardt Ltd's market cap?
Wockhardt Ltd (WOCKPHARMA) has a reported market cap of $325.63B (data as of 2026-07-10).
What is WOCKPHARMA's P/E ratio?
The price-to-earnings (P/E) ratio for Wockhardt Ltd (WOCKPHARMA) is 102.72 (data as of 2026-07-10).
Does Wockhardt Ltd pay a dividend?
Wockhardt Ltd (WOCKPHARMA) shows a reported dividend yield of 0.50%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Wockhardt Ltd in?
Wockhardt Ltd (WOCKPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is WOCKPHARMA listed on?
WOCKPHARMA is listed on NS.
What is Wockhardt Ltd's net margin?
Wockhardt Ltd (WOCKPHARMA) reports a net margin of -6.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.